Related Articles
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
Glasgow Prognostic Score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seeding
Pemetrexed clinical studies in performance status 2 patients with non-small cell lung cancer (Review)
Use of a novel herbal medicine in a 75‑year‑old woman with multi‑metastatic pancreatic cancer: A case report and review of the literature
Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer